In addition, previous works have shown inhibition of Mcl-1 to promote apoptosis and reduce tumor proliferation in Mcl-1 overexpressing osteosarcoma and melanoma cells 30, 31, prompting the preclinical development and clinical trials of Mcl-1 inhibitors 29, 32. Here, MCL1 is linked to neoplasm.